Women's Health

For more than a decade, the Feminist Majority Foundation has been encouraging and advocating for clinical trials using mifepristone, anti-progesterone compound medication formerly known as RU 486 (the abortion pill), for progesterone-receptor positive cancers primarily affecting women. Now, the Feminist Majority Foundation has put together a team of prestigious clinical researchers, attorneys, and FDA specialists, and is moving ahead with Phase II clinical trials for women with progesterone-dependent uterine and ovarian cancers. This type of cancer accounts for 60 percent of breast cancers, 85 percent of uterine cancers and 40 percent of ovarian cancers. Your help is crucial in moving the ground-breaking research forward. We need you to make as large a contribution as you possibly can afford. We want you to participate. When all else fails, feminists will and can make women's health research move forward. Move Women's Cancer Research Forward FMF's Mifepristone Compassionate Use Program Breast Cancer Resources Reproductive Rights Women's Health News 5/12/2008 Quitting Smoking Significantly Decreases Women's Health Risks GO>> 4/29/2008 Study Links High Doses of HRT to Increased Risk of Stroke GO>> 4/28/2008 $11 Million Grant Provides HPV Vaccine to 30,000 Women and Girls in Missouri GO>> 4/25/2008 Iowa Governor Sign HPV Vaccine Law GO>> 4/10/2008 Jackie Speier to be Sworn In to Congress GO>>       October is Breast Cancer Awareness Month Learn more at the Breast Cancer Information Center, and look for articles in the Fall 2005 issue of Ms. Magazine.